BCM
ALXN
Bayesian Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,100
| Closed | -$1.24M | – | 725 |
|
|
2021
Q1 | $1.24M | Buy |
8,100
+4,200
| +108% | +$642K | 0.29% | 92 |
|
|
2020
Q4 | $609K | Buy |
+3,900
| New | +$609K | 0.16% | 183 |
|
|
2020
Q3 | – | Sell |
-3,009
| Closed | -$338K | – | 760 |
|
|
2020
Q2 | $338K | Sell |
3,009
-8,637
| -74% | -$970K | 0.07% | 324 |
|
|
2020
Q1 | $1.05M | Buy |
11,646
+8,146
| +233% | +$732K | 0.23% | 122 |
|
|
2019
Q4 | $379K | Sell |
3,500
-3,577
| -51% | -$387K | 0.06% | 364 |
|
|
2019
Q3 | $693K | Buy |
+7,077
| New | +$693K | 0.13% | 214 |
|
|
2019
Q1 | – | Sell |
-5,611
| Closed | -$546K | – | 823 |
|
|
2018
Q4 | $546K | Buy |
+5,611
| New | +$546K | 0.11% | 261 |
|
|
2017
Q4 | – | Sell |
-9,300
| Closed | -$1.31M | – | 779 |
|
|
2017
Q3 | $1.31M | Buy |
+9,300
| New | +$1.31M | 0.31% | 96 |
|
|
2017
Q1 | – | Sell |
-6,282
| Closed | -$769K | – | 765 |
|
|
2016
Q4 | $769K | Buy |
6,282
+1,082
| +21% | +$132K | 0.19% | 198 |
|
|
2016
Q3 | $637K | Buy |
+5,200
| New | +$637K | 0.42% | 75 |
|